Papers

6

Total Citations

105

H-Index

4

About

Jung Ki Jo is a urologic surgeon and researcher whose work centers on improving outcomes for prostate cancer patients, particularly through robotic surgery and advanced biopsy techniques. His most impactful contribution comes from a prospective randomized trial demonstrating that starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy (RALP) significantly improves erectile function recovery compared to delayed treatment—a finding cited 55 times that has influenced postoperative care protocols. He also showed that intravesical prostatic protrusion (IPP) is a key predictor of urinary continence recovery after RALP, providing surgeons with a preoperative metric to counsel patients (32 citations). More recently, Jo has pioneered MRI-compatible biopsy devices, including a novel cam-based automatic system and a multiple-tissue collection device, enabling more precise, real-time sampling under MRI guidance. His work bridges surgical technique and biomedical engineering, addressing both functional recovery after prostatectomy and diagnostic accuracy. Jo’s research has direct clinical impact, helping surgeons optimize timing of rehabilitation and improve biopsy quality for prostate cancer management.

Research Focus

Key Achievements

4
H-Index
6
Papers
105
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Starting Penile Rehabilitation with Sildenafil Immediately after Robot-Assisted Laparoscopic Radical Prostatectomy on Erectile Function Recovery: A Prospective Randomized Trial
55 citations · 2018
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Hanyang University Seoul Hospital, Hanyang University, Chonnam National University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago